Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Coupled with the results of other small studies involving other interventions, these findings suggest that there is considerable hope in addressing cognitive and functional deficits in BD.118”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 2×
“Taking into account the scarcity of adequately powered randomized trials and discrepant results on research in this field, it will be highly recommendable to conduct further studies investigating treatments targeting cognition in bipolar patients following the Consolidated Standards for Reporting Trials (Moher et al.,…”
BackgroundYatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Stern, Y. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.004 · Cited by 2,943
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationCuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377 · cited 1×
“This framework incorporates genetics, neuroimaging, and cognitive sciences for a new classification of mental disorders (Cuthbert, 2014), where the cognitive system is among the proposed higher order domains.”
MethodBora, E., Yucel, M., & Pantelis, C. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.009 · Cited by 1,022 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundA meta-analysis of cognitive deficits in euthymic patients with bipolar disorder
Robinson, L. J., Thompson, J. M., Gallagher, P., Goswami, U., Young, A. H., Ferrier, I. N., & Moore, P. B. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.016 · Cited by 962 · cited 1×
“Data from different meta-analyses confirm that most patients with bipolar disorder show neurocognitive dysfunction, even during euthymia (Robinson et al., 2006; Bourne et al., 2013; Bortolato et al., 2015).”
Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
Arts, B., Jabben, N., Krabbendam, L., & van Os, J. (2008) · Psychological Medicine · doi:10.1017/s0033291707001675 · Cited by 707 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundBourne, C., Aydemir, Ö., Balanzá‐Martínez, V., Bora, E., Brissos, S., Cavanagh, J. T. O., Clark, L., Cubukcuoglu, Z., Dias, V. V., Dittmann, S., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12133 · Cited by 644
Self-citation
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“Coupled with other small studies involving other interventions, there is considerable hope in addressing cognitive and functional deficits in BD (118).”
Self-citationMalhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
“Cognitive remediation has typically been provided in a structured group format, teaching skills and problem-solving strategies to compensate for cognition-related challenges, but other modalities including digitally delivered interventions are under development (Sole et al., 2017).”
BackgroundEarly Intervention in Bipolar Disorder
Vieta, E., Salagre, E., Grande, I., Carvalho, A. F., Fernandes, B. S., Berk, M., Birmaher, B., Tohen, M., & Suppes, T. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17090972 · Cited by 354
Self-citationEvidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0835-5 · Cited by 204
Self-citationPhytochemicals and cognitive health: Are flavonoids doing the trick?
Bakoyiannis, I., Daskalopoulou, A., Pergialiotis, V., & Perrea, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.086 · Cited by 185
Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder
Bonnín, C. D. M., Reinares, M., Martínez-Arán, A., Jiménez, E., Sánchez-Moreno, J., Solé, B., Montejo, L., & Vieta, E. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz018 · Cited by 158
“, 2018); in this sense, the type and duration of interventions might differ from patients recently diagnosed and patients with a complex course of the illness who might take advantage of restorative therapies such as cognitive and FR (Solé et al., 2017).”
BackgroundSelf-citationSyan, S. K., Smith, M., Frey, B. N., Remtulla, R., Kapczinski, F. P., Hall, G. B., & Minuzzi, L. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170175 · Cited by 156
Sun, Y. R., Herrmann, N., Scott, C. J. M., Black, S. E., Khan, M. M., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.078 · Cited by 142
Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression
Hamer, J., Testani, D. A., Mansur, R. B., Lee, Y. L., Subramaniapillai, M., & McIntyre, R. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.016 · Cited by 146
Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster‐analytic approach
Solé, B., Bonnín, C. D. M., Jiménez, E., Torrent, C., Torres, I. J., Varo, C., Valls, E., Montejo, L., Gómez-Ocaña, C., Tomioka, Y., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12871 · Cited by 119
“As it has previously been suggested (39, 67, 68), one way forward to achieving optimal levels of functioning for bipolar patients would be minimizing the effects of residual symptoms and neurocognitive impairment as they may be two central factors contributing to functional impairment.”
Self-citationToward Precision Psychiatry in Bipolar Disorder: Staging 2.0
Salagre, E., Dodd, S., Aedo, A., Rosa, A., Amoretti, S., Pinzon, J., Reinares, M., Berk, M., Kapczinski, F. P., Vieta, E., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00641 · Cited by 106
Self-citationLi, W., Zhou, F., Zhang, L., Ng, C. H., Ungvari, G. S., Li, J., & Xiang, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.051 · Cited by 118
Bi, B., Che, D., & Bai, Y. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01917-x · Cited by 111
“INTRODUCTION Bipolar disorder (BD) is a complex psychiatric disorder characterized by severe mood fluctuations associated with dysfunctional cognition that often persist throughout the entire life of patients and abnormal psychomotor activity [1, 2].”
BackgroundWang, J., Wang, Y., Wu, X., Huang, H., Jia, Y., Zhong, S., Wu, X., Zhao, L., He, Y., Huang, L., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9978-x · Cited by 94
Cognitive reserve as an outcome predictor: first‐episode affective versus non‐affective psychosis
Amoretti, S., Cabrera, B., Torrent, C., Mezquida, G., Lobo, A., González-Pinto, A. M., Parellada, M., Corripio, I., Vieta, E., de la Serna, E., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12949 · Cited by 99
Self-citationSánchez‐Moreno, J., Bonnín, C. D. M., González-Pinto, A. M., Amann, B. L., Solé, B., Balanzá‐Martínez, V., Arango, C., Jiménez, E., Tabarés‐Seisdedos, R., García‐Portilla, M. P., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12894 · Cited by 104
“The treatment of neurocognitive impairment is still an area of development and innovation and, maybe, different treatments might be required depending on the stage of the illness (34, 71).”
BackgroundSelf-citationDefault mode network activity in bipolar disorder
Zovetti, N., Rossetti, M. G., Perlini, C., Maggioni, E., Bontempi, P., Bellani, M., & Brambilla, P. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020000803 · Cited by 87
Identifying cognitive subgroups in bipolar disorder: A cluster analysis
Lima, F. M., Rabelo‐da‐Ponte, F. D., Bücker, J., Czepielewski, L. S., Hasse-Sousa, M., Cordeiro, R. T. A., Solé, B., Reinares, M., Vieta, E., & Rosa, A. R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.044 · Cited by 87
Self-citationVanderplow, A. M., Eagle, A. L., Kermath, B. A., Bjornson, K. J., Robison, A. J., & Cahill, M. E. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.008 · Cited by 77
Encore: Behavioural animal models of stress, depression and mood disorders
Petković, A., & Chaudhury, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.931964 · Cited by 85
“These disorders are accompanied by alterations in individuals’ perception of social reality, adaptive ability, and executive functioning (Ferreri et al., 2011; Millan et al., 2012; Weightman et al., 2014; Solé et al., 2017; Italia et al., 2020).”
BackgroundYang, L., Zhao, D., Kong, L.-L., Sun, Y.-Q., Wang, Z.-Y., Gao, Y., Li, N., Lu, L. N., Shi, L., Wang, X., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.102 · Cited by 71
Bipolar disorder: definition, differential diagnosis, clinical contexts and therapeutic approaches
Perrotta, G. (2019) · Neuroscience and Neurological Surgery · doi:10.31579/2578-8868/097 · Cited by 64
“Clinical strategies for the management of the disorder [27-34]”
BackgroundComes, A. L., Senner, F., Budde, M., Adorjan, K., Anderson‐Schmidt, H., Andlauer, T. F. M., Gade, K., Heilbronner, M., Heilbronner, U., Kalman, J. L., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0547-x · Cited by 83
Ciullo, V., Spalletta, G., Caltagirone, C., Banaj, N., Vecchio, D., Piras, F., & Piras, F. (2020) · The Neuroscientist · doi:10.1177/1073858420936167 · Cited by 62
McIntyre, R. S., Daniel, D. G., Vieta, E., Laszlovszky, I., Goetghebeur, P., Earley, W. R., & Patel, M. (2022) · CNS Spectrums · doi:10.1017/s109285292200013x · Cited by 57
“Although bipolar disorder and schizophrenia are distinct diagnostic entities based on their clinical presentations, neurocognitive impairment is recognized as a core feature of both disorders(2); approximately 40% to 60% of patients with bipolar disorder and up to 75% of patients with schizophrenia experience cognitiv…”
BackgroundResultSelf-citationCognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability
Amoretti, S., Cabrera, B., Torrent, C., Bonnín, C. D. M., Mezquida, G., Garriga, M., Jiménez, E., Martínez‐Arán, A., Solé, B., Reinares, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050586 · Cited by 61
Self-citationOtt, C. V., Johnson, C. B., Macoveanu, J., & Miskowiak, K. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.01.105 · Cited by 55
Schumer, M. C., Chase, H. W., Rozovsky, R., Eickhoff, S. B., & Phillips, M. L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01974-8 · Cited by 65
“…as stimuli representing or invoking happiness, pleasure, or rewards ; mixed valence was operationalized as positive and negative valence stimuli/conditions collapsed (e.g., all emotional faces vs. baseline); neutral was de fi ned as a non-emotional condition or stimulus (e.g., blank face, shape).”
BackgroundBarbosa, I. G., Ferreira, R. D. A., Rocha, N. P., Mol, G. C., Leite, F. D. M. C., Bauer, I. E., & Teixeira, A. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.003 · Cited by 56
Tsapekos, D., Seccomandi, B., Mantingh, T., Cella, M., Wykes, T., & Young, A. H. (2019) · Bipolar Disorders · doi:10.1111/bdi.12848 · Cited by 50
Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
Kjærstad, H. L., Mistarz, N. T., Coello, K., Stanislaus, S., Melbye, S. A., Harmer, C. J., Vinberg, M., Miskowiak, K. W., & Kessing, L. V. (2019) · Psychological Medicine · doi:10.1017/s0033291719001867 · Cited by 50
Filho, A. J. M. C., Cunha, N. L., de Souza, A. G., Soares, M. V.-R., Jucá, P. M., de Queiroz, T., Oliveira, J. V. S., Valvassori, S. S., Barichello, T., Quevedo, J., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109872 · Cited by 49
Perra, A., Riccardo, C. L., Lorenzo, V. D., Marco, E. D., Natale, L. D., Kurotschka, P. K., Preti, A., & Carta, M. G. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021527 · Cited by 51
Pacchiarotti, I., Anmella, G., Colomer, L., & Vieta, E. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13209 · Cited by 51
Self-citationLe, G. H., Wong, S., Haikazian, S., Johnson, D. E., Badulescu, S., Kwan, A. T. H., Gill, H., Vincenzo, J. D. D., Rosenblat, J. D., Mansur, R. B., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.057 · Cited by 54
Self-citationBonnín, C. D. M., Jiménez, E., Solé, B., Torrent, C., Raduà, J., Reinares, M., Grande, I., Ruíz, V., Sánchez‐Moreno, J., Martínez‐Arán, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071046 · Cited by 47
“Ultimately, the enhancement of cognition (or by guaranteeing its preservation) could also prevent from functional decline [90].”
BackgroundSelf-citationResting state networks activity in euthymic bipolar disorder
Bellani, M., Bontempi, P., Zovetti, N., Rossetti, M. G., Perlini, C., Dusi, N., Squarcina, L., Marinelli, V., Zoccatelli, G., Alessandrini, F., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12900 · Cited by 41
“Partially in line with previous evidence, the within-network analysis revealed lower functional connectivity within the visual, Variables HC BD Statistic P-value Gender (F/M) 21/6 10/5 2 = 0.6158 .43 Age (SD, range) 37 (10.6, 22–60) 40.2 (13.5, 20–61) t = 0.8489 .40 Education, years (SD, range) 15.8 (3, 8–18) 9.6 (3.6…”
InfluentialO’Donnell, C. M., Barrett, D. W., Fink, L. H. L., Garcia-Pittman, E. C., & Gonzalez-Lima, F. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720988906 · Cited by 40
“There is no effective or accepted treatment for cognitive impairment in individuals with BD.58 This proof of concept study is the first to examine sham-controlled effects of TILS on cognition in older adults with BD.”
BackgroundInfluentialPerra, A., Galetti, A., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Primavera, D., Natale, L. D., Nardi, A. E., Kurotschka, P. K., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062142 · Cited by 44
Investigating the neural basis of cognitive control dysfunction in mood disorders
Breukelaar, I. A., Erlinger, M., Harris, A. W. F., Boyce, P. M., Hazell, P., Grieve, S. M., Antees, C., Foster, S., Gomes, L. J., Williams, L. M., et al. (2019) · Bipolar Disorders · doi:10.1111/bdi.12844 · Cited by 40
“Anti‐convulsant, number (%) 14 (48) — —”
The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis
Chen, M., Jiang, Q., & Zhang, L. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-2293 · Cited by 42
“Although bipolar disorder is defined by the presence of manic or manic symptoms, most patients spend most of their time in a state of depression, which is the main cause of disability (24).”
BackgroundThe association between C-reactive protein, mood disorder, and cognitive function in UK Biobank
Milton, D. C., Ward, J., Ward, E., Lyall, D. M., Strawbridge, R. J., Smıth, D. J., & Cullen, B. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.6 · Cited by 39
“The observed association between mood disorder and worse cognitive function is in line with previous research [12-14].”
BackgroundResultPsychosocial rehabilitation interventions in the treatment of schizophrenia and bipolar disorder
Yıldız, M. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27430 · Cited by 62
“A pharmacotherapy effective on cognitive impairment is not yet known (50).”
BackgroundRemote cognitive assessment in severe mental illness: a scoping review
Lavigne, K. M., Sauvé, G., Raucher‐Chéné, D., Guimond, S., Lecomte, T., Bowie, C. R., Menon, M., Lal, S., Woodward, T. S., Bodnar, M. D., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00219-x · Cited by 36
“(2021)(86) Schizoaffective (35) Schizophrenia (34) Bipolar w/ psychosis (15) Depression w/ psychosis (2) 86 Smartphone Remote Unspecified web-based Smartphone Capable Application Mobile Face Emotion Task SC”
BackgroundZhong, B., Xu, Y., Xie, W., & Li, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.010 · Cited by 36
Suicidal behaviour and cognition: A systematic review with special focus on prefrontal deficits
Fernández-Sevillano, J., González-Pinto, A. M., Rodríguez-Revuelta, J., Alberich, S., González-Blanco, L., Zorrilla, E. P., Velasco, Á., López, M. P., Abad, I., & Sáiz, P. A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.044 · Cited by 40
Three‐year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder
Torres, I. J., Qian, H., Basivireddy, J., Chakrabarty, T., Wong, H., Lam, R. W. M., & Yatham, L. N. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13141 · Cited by 37
“Such knowledge is crucial in helping to understand the etiology of the illness and its associated cognitive impairments and to determine whether these deficits may be modifiable or responsive to early interventions (8).”
BackgroundSelf-citationSaldarini, F., Gottlieb, N., & Stokes, P. R. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.084 · Cited by 33
A clinical staging model for bipolar disorder: longitudinal approach
de la Fuente-Tomás, L., Sierra, P., Sánchez-Autet, M., Arranz, B., García‐Blanco, A., Safont, G., & García‐Portilla, M. P. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0718-9 · Cited by 36
Sachs, G., Berg, A. V., Jagsch, R., Lenz, G., & Erfurth, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.530026 · Cited by 34
“There is evidence that maintenance pharmacotherapy in conjunction with psychological interventions can improve the outcome (26).”
BackgroundCerebellar Cortex as a Therapeutic Target for Neurostimulation
van Dun, K., Mitoma, H., & Manto, M. U. (2018) · The Cerebellum · doi:10.1007/s12311-018-0976-8 · Cited by 34
The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species
Kageyama, Y., Okura, S., Sukigara, A., Matsunaga, A., Maekubo, K., Oue, T., Ishihara, K., Deguchi, Y., & Inoue, K. (2025) · Biomolecules · doi:10.3390/biom15030383 · Cited by 36
“Some patients may not respond to these pharmacological treatments, potentially resulting in cognitive impairment and social dysfunction [20].”
Luperdi, S. C., Tabarés‐Seisdedos, R., Livianos, L., Vieta, E., Cuesta, M. J., & Balanzá‐Martínez, V. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.014 · Cited by 33
Self-citationVega-Núñez, A., Sánchez-Lafuente, C. G., Mayoral, F., Bordallo-Aragón, A., de Fonseca, F. R., Suárez, J., & Parra, J. G. (2022) · Biomedicines · doi:10.3390/biomedicines10061368 · Cited by 32
Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
Mijailović, N. R., Vesić, K., Arsenijević, D., Milojević‐Rakić, M., & Borovčanin, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.923811 · Cited by 33
“Cognitive dysfunctionalities are observed in the widespan of mental disorders: bipolar disorder (Solé et al., 2017), schizophrenia (Daban et al.”
BackgroundCognitive reserve and cognition in mood disorders: A systematic review and meta-analysis
Camprodon‐Boadas, P., Prisco, M. D., Rabelo‐da‐Ponte, F. D., Sugranyes, G., Clougher, D., Baeza, I., Torrent, C., Castro‐Fornieles, J., Tosetti, Y., Vieta, E., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116083 · Cited by 32
Self-citationOxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats
Roberts, B. Z., Young, J. W., He, Y. V., Cope, Z. A., Shilling, P. D., & Feifel, D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.028 · Cited by 25
“functional outcome, defined as a patient's ability to reintegrate into society (Duarte et al., 2016; Green, 2006; Green et al., 2000; McIntyre et al., 2013; Sole et al., 2017; Woo et al., 2016).”
Chen, W., Huang, M., Lee, Y., Chang, C.-E., Lin, S., Chiu, C. C., Liu, H., Kuo, C., Weng, S., Chen, P., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.684813 · Cited by 27
Bipolar‐associated miR‐499‐5p controls neuroplasticity by downregulating the Cav1.2 subunit CACNB2
Martins, H. C., A.Ö., S., Gilardi, C., Pelzl, M., Bicker, S., Groß, F., Winterer, J., Kisko, T. M., Malikowska‐Racia, N., Braun, M. D., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154420 · Cited by 25
Li, D., Ma, Y., Cui, F., Yang, Y., Liu, R., Tang, L., Wang, J., & Tian, Y. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115396 · Cited by 26
Żabińska, M., Wiśniewska, K., Węgrzyn, G., & Pierzynowska, K. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107070 · Cited by 29
van den Hurk, W., Bergman, I., Machado, A., Bjermo, J., & Gustavsson, A. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772100045x · Cited by 27
“Finally, repeated testing can support evaluation of treatment and recovery by providing an objective measurement (Levey et al., 2006; Schmid & Hammar, 2013; Solé et al., 2017).”
MethodPlatania, G. A., Guerrera, C. S., Sarti, P., Varrasi, S., Pirrone, C., Popović, D., Ventimiglia, A., Vivo, S. D., Cantarella, R. A., Tascedda, F., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276822 · Cited by 25
“This is coherent with the literature sustaining that treating cognitive symptoms is a critical step in the clinical approach to depression, and will help to improve psychosocial functioning, enhance the quality of life and avoid relapses [25, 33, 48].”
BackgroundMardani, P., Hassanvandi, S., Dadashi, M., Zolghadriha, A., Javadani, H., & Mousavi, S. E. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03592-6 · Cited by 21
Xu, X., Xiang, H., Yan, Q., Teng, Z., Li, S., Huang, J., Chen, J., Tang, H., Jin, K., Jiang, L., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.125 · Cited by 23
Sawalha, J., Cao, L., Chen, J., Selvitella, A., Liu, Y. S., Yang, C., Li, X., Zhang, X., Sun, J., Zhang, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.046 · Cited by 19
Jiang, J. C., Chen, Y., Lin, Z., Liu, S., Chen, X., & Chen, Q. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119638 · Cited by 31
Anhedonia in bipolar depression treated with ketamine
Wilkowska, A., Wiglusz, M. S., Arciszewska, A., Gałuszko‐Węgielnik, M., & Cubała, W. J. (2024) · Bipolar Disorders · doi:10.1111/bdi.13409 · Cited by 19
Nazari, M.-J., Shalbafan, M., Eissazade, N., Khalilian, E., Vahabi, Z., Masjedi, N., Ghidary, S. S., Saadat, M., & Sadegh‐Zadeh, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303699 · Cited by 18
Lengvenytė, A., Coppola, F., Jaussent, I., Courtet, P., & Olié, É. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.062 · Cited by 19
Luperdi, S. C., Correa‐Ghisays, P., Vila‐Francés, J., Selva‐Vera, G., Salazar-Fraile, J., Cardoner, N., Ruíz-Veguilla, M., Livianos, L., Tabarés‐Seisdedos, R., & Balanzá‐Martínez, V. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.07.008 · Cited by 20
“Third, concerning the patient’s group, moderators such as chronicity, stage of illness, number of episodes, and other clinical variables such as obesity and metabolic disorders were not considered (Mora et al., 2017; Solé et al., 2017).”
BackgroundEffect of valproate and lithium on dementia onset risk in bipolar disorder patients
Moon, W., Ji, E., Shin, J., Kwon, J. S., & Kim, K. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-18350-1 · Cited by 19
The perils of being too stable: mood regulation in bipolar disorder
Ortiz, A., & Alda, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180183 · Cited by 17
Soh, J. F., Almadani, A. H., Beaulieu, S., Rajji, T. K., Mulsant, B. H., Su, C., Renaud, S., Mucsi, I., Torres-Platas, S. G., LEVINSON, A. J., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.013 · Cited by 17
Zhou, J., Ma, X., Li, C., Liao, A., Yang, Z., Ren, H., Tang, J., Li, J., Li, Z., Hé, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.574819 · Cited by 18
Liu, B., Chen, B., Yi, J., Long, H., Wen, H., Tian, F., Liu, Y., Xiao, L., & Li, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.949298 · Cited by 24
Perra, A., Lorenzo, V. D., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Natale, L. D., Galetti, A., Nardi, A. E., Cossu, G., et al. (2022) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v18-e2208220 · Cited by 19
Early use of long‐acting injectable antipsychotics in bipolar disorder type I: An expert consensus
Vieta, E., Tohen, M. F., McIntosh, D., Kessing, L. V., Sajatovic, M., & McIntyre, R. S. (2024) · Bipolar Disorders · doi:10.1111/bdi.13498 · Cited by 21
Self-citationThe relationship between “Eyes Reading” ability and verbal memory in bipolar disorder
Dalkner, N., Bengesser, S., Birner, A., Fellendorf, F. T., Hamm, C., Platzer, M., Pilz, R., Queissner, R., Rieger, A., Weber, B., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.015 · Cited by 18
Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape
Watts, D., Pfaffenseller, B., Wollenhaupt-Aguiar, B., Géa, L. P., Cardoso, T. D. A., & Kapczinski, F. P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1581764 · Cited by 20
“Mood episodes in BD are associated with poorer patient outcomes, including functional impairment [2,3], suicide attempts [4], and considerable economic costs on a societal level [5].”
BackgroundCastellano, S., Torrent, C., Petralia, M. C., Godos, J., Cantarella, R. A., Ventimiglia, A., Vivo, S. D., Platania, S., Guarnera, M. A., Pirrone, C., et al. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s224754 · Cited by 17
“It is well known that cognitive performance strongly affects psychosocial functioning and, particularly, working ability in patients diagnosed with MDD(7) as well as with bipolar disorder.(8,9) A study conducted by Bonnìn et al(10) on bipolar patients showed that depressive symptoms, combined with neurocognitive damag…”
BackgroundSelf-citationCahn, A. J., Keramatian, K., Frysch, C., Yatham, L. N., & Chakrabarty, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.04.051 · Cited by 17
Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls
Strenn, N., Pålsson, E., Liberg, B., Landén, M., & Ekman, A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113606 · Cited by 16
“Studies have shown cognitive impairment associated with the disorder (Abé et al., 2018; Pålsson et al., 2013; Rolstad et al., 2016; Solé et al., 2017; Sparding et al., 2015) along with structural and neurophysiological changes (Abé et al., 2019, 2016; Berk et al., 2011; Hibar et al., 2018).”
BackgroundZhou, X., Wu, B., Liu, W., Xiao, Q., He, W., Zhou, Y., Wei, P., Zhang, X., Liu, Y., Wang, J., et al. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00731-7 · Cited by 15
Keshavarzi, A., Sharifi, A., Jahangard, L., Soltanian, A. R., Brühl, A. B., Ahmadpanah, M., & Brand, S. (2022) · Neuropsychobiology · doi:10.1159/000520457 · Cited by 15
Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance
Akkouh, I. A., Ueland, T., Andreassen, O. A., Brattbakk, H.-R., Steen, V. M., Hughes, T., & Djurovic, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-30898-5 · Cited by 20
Ahmadpanah, M., Pezeshki, R., Soltanian, A. R., Jahangard, L., Dürsteler, K. M., Keshavarzi, A., & Brand, S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.12.035 · Cited by 15
Bernabei, L., Bersani, F. S., Pompili, E., Chiaie, R. D., Valente, D., Corrado, A., Vergnani, L., Ferracuti, S., Biondi, M., & Fornari, M. A. C. D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.073 · Cited by 18
Long-term outcome predictors after functional remediation in patients with bipolar disorder
Solé, B., Bonnín, C. M., Radua, J., Montejo, L., Hogg, B., Jimenez, E., Reinares, M., Valls, E., Varo, C., Pacchiarotti, I., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720001968 · Cited by 17
“It is important to underscore the considerable variation between studies in terms of how cognitive interventions were delivered, their contents, the treatment duration, the intensity of each of them, and the primary outcome (cognition v. psychosocial functioning) (Solé et al., 2017).”
BackgroundSelf-citationZazula, R., Mohebbi, M., Dodd, S., Dean, O. M., Berk, M., Vargas, H. O., & Nunes, S. O. V. (2021) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acab054 · Cited by 20
Transdiagnostic features of inflammatory markers and executive function across psychiatric disorders
Wang, T., Chang, Y., Lee, S.-Y., Chang, H. H., Tsai, T.-Y., Tseng, H., Wang, S., Chen, P. S., Chen, K. C., Lee, I. H., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.11.037 · Cited by 16
Cotter, J., Barnett, J. H., & Granger, K. T. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00648 · Cited by 14
Efficacy and safety of cariprazine in the treatment of bipolar disorder
Saraf, G., Pinto, J. V., & Yatham, L. N. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1660319 · Cited by 17
“addition, it has now been established that BD patients have cognitive deficits in the euthymic periods as well, which are not targeted adequately by existing treatments [16,17].”
BackgroundNeuroimaging Studies of Brain Structure in Older Adults with Bipolar Disorder: A Review
Rajashekar, N., Blumberg, H. P., & Villa, L. M. (2022) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20220006 · Cited by 16
“As cognitive decline is a feature for some individuals with BD during later life, that causes suffering, impaired functioning, and is associated with poor prognosis [79], elucidating disturbances in these key WM tracts may be integral to preventing some of the severe clinical outcomes associated with BD during later l…”
BackgroundZhang, L., Ding, Y., Li, T., Li, H., Liu, F., Li, P., Zhao, J., Lv, D., Lang, B., & Guo, W. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115868 · Cited by 13
Congio, A. C., Urbano, M. R., Soares, M. R. Z., & Nunes, S. O. V. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.07.052 · Cited by 14
Existing and emerging pharmacological approaches to the treatment of mania: A critical overview
Sparacino, G., Verdolini, N., Vieta, E., & Pacchiarotti, I. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01928-8 · Cited by 14
Self-citationYan, S., Pang, M., Wang, J., Chen, R., Liu, H., Xu, X., Li, B., Li, Q., & Kong, F. (2023) · Health Economics Review · doi:10.1186/s13561-023-00470-7 · Cited by 13
Primavera, D., González, C. I. A., Perra, A., Kalcev, G., Cantone, E., Cossu, G., Holzinger, A., Carta, M. G., & Sancassiani, F. (2024) · Healthcare · doi:10.3390/healthcare12171753 · Cited by 12
Macellaro, M., Girone, N., Cremaschi, L., Bosi, M. F., Cesana, B. M., Ambrogi, F., Caricasole, V., Giorgetti, F., Ketter, T. A., & Dell’Osso, B. M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.081 · Cited by 12
Metadata
- Authors
- Solé, B., Jiménez, E., Torrent, C., Reinares, M., Bonnin, C. D. M., Torres, I., Varo, C., Grande, I., Valls, E., Salagre, E., Sanchez-Moreno, J., Martinez-Aran, A., Carvalho, A. F., & Vieta, E.
- Affiliations
- Universidade Federal do Ceará (BR)
- Corresponding author
- Vieta, Eduard
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-11
- Volume
- 20
- Issue
- 8
- Pages
- 670-680
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5570032
- OpenAlex
- W2613431376
- Cited by
- 299
- References
- 125
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 48 · 2023: 28 · 2022: 40 · 2021: 37 · 2020: 34 · 2019: 24 · 2018: 21 · 2017: 1
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Generalitat de Catalunya (2014_ SGR_398)
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Ministerio de Economía y Competitividad (PI12/00912, PI12/, CPI14/00175)
- Centro de Investigación Biomédica en Red de Salud Mental
- Instituto de Salud Carlos III (PI11/, CPI14/00175, 00012, PI15/00330, JR15/00012, 2008-2011)
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, cognitive impairment, neurocognitive impairment, cognitive impairment prevention, pharmacotherapy, psychological intervention, psychosocial functioning
- MeSH terms
- Bipolar Disorder, Humans, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
